Silencing MAP3K7 diminished cell growth in HCC cell lines without or with wild-type or mutant TP53, implying that the effect of MAP3K7 on cell proliferation might be in an HBV- and TP53-independent manner. Here, TP53 is linked to hepatocellular carcinoma.